Lactic acidosis rates in type 2 diabetes

Diabetes Care

Volumn 21, Issue 10, 1998, Pages 1659-1663

  Brown, Jonathan B ^a,d   Pedula, Kathryn ^a   Barzilay, Joshua ^c   Herson, Michael K ^b   Latare, Peggy ^c  

^a KAISER PERMANENTE   (United States)

^b Northwest Permanente   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ADULT; AGED; ANALYTIC METHOD; ARTERIAL PH; ARTICLE; DIABETES CONTROL; FEMALE; HUMAN; INCIDENCE; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ACIDOSIS, LACTIC; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; METFORMIN; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 0031685819     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.10.1659     Document Type: Article

References (30)

1. Potin M, Perret C: Lactic acidosis and hyperlactatemia. Rev Prat 40:2042-2046, 1990
2. Cohen RD, Woods HF: The clinical presentations and classifications of lactic acidosis. In Clinical and Biochemical Aspects of Lactic Acidosis. Cohen RD, Woods HF, Eds. Boston, MA, Blackwell, 1976
3. Arieff AI: Pathogenesis of lactic acidosis. Diabetes Metab Rev 5:637-649, 1989
4. Stacpoole PW: Lactic acidosis. Endocrinol Metab Clin North Am 22:221-245, 1993
5. Vigneri R, Goldnne ID: Role of metformin in treatment of diabetes mellitus, Diabetes Care 10:118-122, 1987
6. Assan R, Girard JR, George J, Bismuth C, Ganeval D, Heuclin C: Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia 13:211-217, 1977
7. Hutchison SMW, Catterall JR: Metfonnin and lactic acidosis: a reminder. Br J Clin Pract 41:673-674, 1987
8. Lucis OJ: The status of metformin in Canada, Can Med Assoc J 128:24-26, 1983
9. Misbin RI, Green L, Stadel BY Gueriguian JL, Gabbi A, Fleming GA: Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265-266, 1998
10. Sulkin TV, Bosman D, Krentz AJ: Contraindications of metformin therapy with NIDDM. Diabetes Care 20:925-928, 1997
11. Wilholm BE, Myrhed M: Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol 44:589-591, 1993
12. Berger W: Diabetic emergencies. Schweiz Rundsch Med Prax 18:308-313, 1997
13. Campbell IW: Metformin and the sulpho nylureas: the comparative risk. Horm Metab Res 15:105-111, 1985
14. Lebech M, Olesen LL: Lactic acidosis associated with metformin. Ugeskr Laeger 152:2511-2512, 1990
15. Rosner B: Fundamentals of Biostatistics. Boston, MA, PWS, 1986, p. 115
16. Goo AKY, Carson DS, Bjelajac A: Metformin: a new treatment option for noninsulin-dependent diabetes mellitus. J Fam Pract 42:612-618, 1996
17. McNamee M, Bartek JK: Metformin: prevention of lactic acidosis. Urol Nurs 16:71-72, 1996
18. Bressler R, Johnson DG: Pharmacological regulation of blood glucose levels in noninsulin-dependent diabetes mellitus. Arch Intern Med 157:836-848, 1997
19. Sirtori CR, Conti F, Bondioli A, Cighetti G, Galli-Kienle M, Franceschini G: Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther 24:683-693, 1978
20. Pentikainen PJ, Neuvonen PJ, Pentila A: Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol 16:195-202, 1979
21. Tucker GT, Woods HF, Ward JD, Connor H, Phillips PJ, Casey C: Metformin kinetics in healthy subjects and in patients with dia- betes mellitus. Br J Clin Pharmacol 12:235-246, 1981
22. Campbell RK, White JR, Saulie BA: Metformin: a new oral biguanide. Clin Ther 18:360-371, 1996
23. Sirtori CR, Pasik C: Re-evaluation of a biguanide, metformin: mechanism of action and tolerability Pharmacol Res 30:187-227, 1994
24. Bailey CJ: Biguanides and NIDDM. Diabetes Care 15:755-772, 1992
25. Dunn CJ, Peters DH: Metformin: a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49:721-749, 1995
26. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554, 1995
27. Clarke BF, Duncan LJP: Biguanide treatment in the management of insulin independent (maturity-onset) diabetes: clinical experience with metformin. Res Clin Forums 1:53-63, 1979
28. Phillips PJ, Gilmore HR, Clarkson AR, Scicchitano R: Metformin associated lactic acidosis. Aust N Z J Med 8:281-284, 1978
29. Dagogo-Jack S, Santiago JV: Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions, Arch Intern Med 157:1802-1817, 1997
30. Lalau JD, Lacroix C, Compagnon P, De Cagny B, Rigaud JR Bleichner G, Chauveau P, Dulbecco P, Guérin C, Haegy JM, Loirat P, Marchand B, Ravaud Y, Weyne P, Foumier A: Role of metformin accumulation in metformin associated lactic acidosis. Diabetes Care 18:779-785, 1995